Patent ID: 7160910
Filing Date: 2007-01-09
Classification: A61K,A61P,C07D,Y02P

Abstract:
1. A method for treating sickle cell disease in a patient in need thereof, comprising the step of administering to said patient a compound of the formula: where R1 is CHO or a thiozolidine group of the following formula: R2, R3 and R4 are the same or different and selected from the group consisting of H, OH, alkyl, halogen and hydroxy-alkyl; R6 and R7=H; X=O or S; and wherein said compound is administered in sufficient amount to said patient to ameliorate sickle cell disease, with the proviso that R2,R3 and R4 cannot be H or alkyl at the same time when R1 is CHO and X is O.